# Thoraco Lumbar Vertebral Length and Bupivacaine Dosage in C-Section

> **NCT06869434** · NA · COMPLETED · sponsor: **TC Erciyes University** · enrollment: 446 (actual)

## Conditions studied

- Obstetric Anesthesia Problems
- Bupivacaine Adverse Reaction

## Interventions

- **PROCEDURE:** Group VBL (Thoracolumbal vertebral body length) received 0.2 mg x VBL cm of %0.5 hyperbaric bupivacaine
- **PROCEDURE:** Group FD (fixed dose) received a volume of 0.5% hyperbaric bupivacaine based on a dose calculated according to the patient's height 0.065 mg/cm
- **PROCEDURE:** Group AD (adjusted dosage) got intrathecal heavy bupivacaine (0.5%) tailored to the patient's height and weight.

## Key facts

- **NCT ID:** NCT06869434
- **Lead sponsor:** TC Erciyes University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-05-20
- **Primary completion:** 2025-12-01
- **Final completion:** 2025-12-15
- **Target enrollment:** 446 (ACTUAL)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06869434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06869434, "Thoraco Lumbar Vertebral Length and Bupivacaine Dosage in C-Section". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06869434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*